Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Jul 2026 for Aptose Biosciences Inc..
Filing timeline
BuySaleFletcher Payne
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -59.6%Entry US$207.00 · Close at T+365 US$83.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fletcher Payne: trading record in brief
Fletcher Payne discloses dealings in 2 companies, chiefly Gyre Therapeutics, Inc. and Aptose Biosciences Inc. The record holds 10 filings, for trades running from 20 August 2015 to 30 June 2026.
No open-market sale appears; the market trades are 2 purchases worth €25k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 share grants and 2 option exercises.
On 1 July 2026 came the latest disclosure, a transaction in Aptose Biosciences Inc. The last insider purchase was made public on 21 September 2022, 1,496 days ago. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Fletcher Payne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
222 sharesCommon SharesSEC:0000912282-26-000895:0
22 sharesCommon SharesSEC:0000912282-26-000895:1
100,000 shares0Common SharesSEC:0001567619-23-001162:0
10,000 shares@ US$0.6775100.0% of flowCommon SharesSEC:0001567619-22-017697:0
Canonical exit: 18 Dec 2022 (T+90)
1,180 shares@ US$6.5135.8% of flowCommon StockSEC:0001209191-19-045506:0
1,002 shares@ US$7.0432.5% of flowCommon StockSEC:0001209191-19-009885:0
1,503 shares@ US$4.6331.7% of flowCommon StockSEC:0001209191-19-006858:0
59 shares@ US$4.631.1% of flowCommon StockSEC:0001209191-18-021896:0
10,000 shares@ US$2.00Common StockSEC:0001209191-15-086171:0
Canonical exit: 16 Mar 2016 (T+90)
15,032 sharesCommon StockSEC:0001209191-15-067186:0
10 of 10 declarations
